APA (7th ed.) Citation

Enzan, N., Matsushima, S., Ide, T., Tohyama, T., Funakoshi, K., Higo, T., & Tsutsui, H. (2022). The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin‐converting enzyme inhibitor in dilated cardiomyopathy. ESC Heart Failure, 9(2), 1175. https://doi.org/10.1002/ehf2.13790

Chicago Style (17th ed.) Citation

Enzan, Nobuyuki, Shouji Matsushima, Tomomi Ide, Takeshi Tohyama, Kouta Funakoshi, Taiki Higo, and Hiroyuki Tsutsui. "The Use of Angiotensin II Receptor Blocker Is Associated with Greater Recovery of Cardiac Function than Angiotensin‐converting Enzyme Inhibitor in Dilated Cardiomyopathy." ESC Heart Failure 9, no. 2 (2022): 1175. https://doi.org/10.1002/ehf2.13790.

MLA (9th ed.) Citation

Enzan, Nobuyuki, et al. "The Use of Angiotensin II Receptor Blocker Is Associated with Greater Recovery of Cardiac Function than Angiotensin‐converting Enzyme Inhibitor in Dilated Cardiomyopathy." ESC Heart Failure, vol. 9, no. 2, 2022, p. 1175, https://doi.org/10.1002/ehf2.13790.